Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,814 | 485 | 70.6% |
| Unspecified | $2,969 | 5 | 19.4% |
| Travel and Lodging | $956.20 | 6 | 6.2% |
| Consulting Fee | $300.00 | 1 | 2.0% |
| Education | $278.37 | 3 | 1.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $2,969 | 5 | $0 (2023) |
| ModernaTX, Inc. | $1,272 | 12 | $0 (2024) |
| ABBVIE INC. | $1,180 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $841.45 | 54 | $0 (2024) |
| UCB, Inc. | $816.16 | 25 | $0 (2024) |
| GENZYME CORPORATION | $718.77 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $698.57 | 22 | $0 (2024) |
| Lilly USA, LLC | $675.79 | 27 | $0 (2024) |
| Almirall LLC | $628.87 | 17 | $0 (2024) |
| PFIZER INC. | $596.58 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,241 | 151 | ModernaTX, Inc. ($1,272) |
| 2023 | $6,818 | 167 | SANOFI US SERVICES INC. ($2,969) |
| 2022 | $1,937 | 85 | Lilly USA, LLC ($355.45) |
| 2021 | $2,321 | 97 | Almirall LLC ($351.58) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $38.95 | General |
| Category: Immunology | ||||||
| 12/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $133.88 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.84 | General |
| 11/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $42.02 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Inflammation & Immunology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $44.49 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Immunology | ||||||
| 10/17/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Inflammation & Immunology | ||||||
| 10/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.80 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study Assessing the Efficacy and Safety of an Anti-TNF-OX40L NANOBODY Molecule, SAR442970, in Participants With Moderate to Severe Hidradenitis Suppurativa | SANOFI US SERVICES INC. | $2,969 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 890 | 1,499 | $213,608 | $58,292 |
| 2022 | 10 | 645 | 1,103 | $251,065 | $47,869 |
| 2021 | 9 | 580 | 1,213 | $205,613 | $42,100 |
| 2020 | 4 | 85 | 150 | $13,464 | $3,863 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 372 | $66,648 | $18,129 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 130 | $32,990 | $10,056 | 30.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 146 | 180 | $35,837 | $9,520 | 26.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 86 | 107 | $23,777 | $6,525 | 27.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 114 | 163 | $21,585 | $4,803 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $8,527 | $2,362 | 27.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 36 | 57 | $5,645 | $1,811 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,665 | $1,699 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 77 | 393 | $5,060 | $1,496 | 29.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 14 | $4,081 | $1,070 | 26.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 25 | $2,794 | $820.60 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 265 | $72,345 | $14,190 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 134 | $51,456 | $10,196 | 19.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 108 | 137 | $41,922 | $8,184 | 19.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 84 | 130 | $26,260 | $4,269 | 16.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 44 | 56 | $18,928 | $3,507 | 18.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $10,540 | $2,053 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $12,168 | $1,908 | 15.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 29 | 41 | $6,273 | $1,367 | 21.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 48 | 272 | $5,440 | $1,114 | 20.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 12 | 13 | $5,733 | $1,081 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 224 | $59,202 | $12,528 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 88 | 110 | $41,695 | $8,668 | 20.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 98 | 123 | $36,896 | $7,471 | 20.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 75 | 110 | $21,071 | $3,855 | 18.3% |
About Casey Viera, ARNP
Casey Viera, ARNP is a Registered Nurse healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1144641556.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Viera, ARNP has received a total of $15,317 in payments from pharmaceutical and medical device companies, with $4,241 received in 2024. These payments were reported across 500 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,814).
As a Medicare-enrolled provider, Viera has provided services to 2,200 Medicare beneficiaries, totaling 3,965 services with total Medicare billing of $152,124. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner
- Location Tampa, FL
- Active Since 01/02/2014
- Last Updated 09/12/2019
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1144641556
Products in Payments
- DUPIXENT (Biological) $1,124
- TREMFYA (Drug) $551.20
- TALTZ (Drug) $533.12
- SKYRIZI (Biological) $514.50
- RINVOQ (Biological) $514.47
- Sotyktu (Drug) $509.31
- ADBRY (Biological) $438.15
- COSENTYX (Biological) $412.01
- Cimzia (Drug) $411.79
- Tolak (Drug) $411.73
- Bimzelx (Biological) $404.37
- COSENTYX (Drug) $390.24
- Seysara (Drug) $328.87
- EUCRISA (Drug) $303.78
- Klisyri (Drug) $300.00
- OPZELURA (Drug) $299.31
- Otezla (Drug) $253.43
- SILIQ (Drug) $241.49
- Winlevi (Drug) $193.24
- VTAMA (Drug) $179.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Tampa
Rebekah Rharad, Aprn, Rn, APRN, RN
Registered Nurse — Payments: $28,349
Ms. Suecarla Adams, Aprn, APRN
Registered Nurse — Payments: $6,688
Mark Nuguid, Aprn, APRN
Registered Nurse — Payments: $2,112
Yessenia Marmol, Aprn, APRN
Registered Nurse — Payments: $1,971
Miss. Maria Estrada, Arnp, ARNP
Registered Nurse — Payments: $1,291
Yaime Alayo Linton
Registered Nurse — Payments: $1,243